When to Consider Perimenopause: Clinical Decision Aid

For primary care clinicians. Based on NICE NG23 and NAMS 2022 Position Statement.

Female patient, age 35-58, presenting with unexplained or multisystem symptoms
Are vasomotor symptoms present?
Hot flashes, night sweats, cold flashes, or flushing
YES
Perimenopause is likely if age 45+.
NICE: diagnose clinically without blood tests in women over 45.
NO
Proceed to assess other symptom clusters below.
Are 2+ of these symptom clusters present?
Menstrual changes (irregular, heavier, lighter) | Cognitive (brain fog, memory) | Mood (anxiety, irritability, depression) | Sleep disruption | Joint pain/stiffness | Decreased libido
YES
Consider perimenopause. Especially if onset is recent and unexplained by other causes.
NO / UNCERTAIN
Consider alternative diagnoses (thyroid, anemia, depression). Re-evaluate in 3-6 months if symptoms persist.
Is the patient under 45?
YES, under 45
Check FSH (x2, 4-6 weeks apart) + estradiol.
Rule out thyroid (TSH), anemia (CBC), pregnancy.
NO, 45+
Clinical diagnosis is sufficient per NICE NG23. Blood tests are not required for women over 45 with typical symptoms.

When to test (FSH)

  • Patient is under 45
  • Premature ovarian insufficiency suspected (under 40)
  • Diagnostic uncertainty
  • Patient on hormonal contraception (consider 6-week washout)
Note: A single normal FSH does not exclude perimenopause. Levels fluctuate significantly.

When to refer to specialist

  • Suspected POI (under 40)
  • Complex HRT decisions (history of VTE, breast cancer, CVD)
  • Treatment-resistant vasomotor symptoms
  • Significant mood/psychiatric symptoms
  • Abnormal uterine bleeding requiring investigation

Initial management considerations

  • Validate symptoms and educate patient
  • Discuss lifestyle modifications
  • Consider HRT if appropriate (see HRT reference card)
  • Screen for cardiovascular risk factors
  • Assess bone health if early menopause
  • Consider CBT for mood/vasomotor symptoms

Key clinical pearls

  • Perimenopause can begin 7-10 years before final period
  • Symptoms may present as seemingly unrelated complaints
  • Regular periods do not exclude perimenopause
  • 40% of perimenopause is missed on blood tests alone
  • Average age of menopause is 51 (range 45-55)
References: NICE Guideline NG23: Menopause: diagnosis and management (updated 2024). NAMS 2022 Position Statement on Hormone Therapy. The Lancet Commission on Menopause (2024).
From MARKABLE - markable.life General reference only. Always apply clinical judgment.
MARKABLE is a general wellness product. It is not a medical device and is not intended to diagnose, treat, cure, or prevent any disease.